Hedge Fund - Knoll Capital Management
Aldeyra Therapeutics Inc. (ALDX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $19,219,061 | 15.91% | 5,475,516 | $3.09 |
| 2 | 2023 - Q3 (2023-09-30) | $20,253,192 | 21.02% | 3,031,915 | $7.42 |
| 3 | 2023 - Q2 (2023-06-30) | $25,301,454 | 30.67% | 3,015,668 | $9.85 |
| 4 | 2023 - Q1 (2023-03-31) | $20,526,898 | 31.63% | 2,067,160 | $7.07 |
| 5 | 2022 - Q4 (2022-12-31) | $13,558,706 | 30.59% | 1,948,090 | $5.72 |
| 6 | 2022 - Q3 (2022-09-30) | $10,025,000 | 5.85% | 1,877,305 | $6.00 |
| 7 | 2022 - Q2 (2022-06-30) | $5,995,000 | 3.42% | 1,502,460 | $3.44 |
| 8 | 2022 - Q1 (2022-03-31) | $3,376,000 | 2.11% | 759,405 | $3.98 |
| 9 | 2021 - Q4 (2021-12-31) | $3,038,000 | 1.66% | 759,405 | $7.63 |
| 10 | 2021 - Q3 (2021-09-30) | $4,999,000 | 2.49% | 569,405 | $9.18 |
| 11 | 2021 - Q2 (2021-06-30) | $6,451,000 | 3.36% | 569,405 | $12.02 |
| 12 | 2021 - Q1 (2021-03-31) | $6,765,000 | 4.4% | 569,405 | $11.52 |
| 13 | 2020 - Q4 (2020-12-31) | $3,906,000 | 2.66% | 569,405 | $7.02 |
| 14 | 2020 - Q3 (2020-09-30) | $4,219,000 | 3.45% | 569,405 | $6.46 |
| 15 | 2020 - Q2 (2020-06-30) | $2,374,000 | 1.37% | 569,405 | $3.65 |
| 16 | 2020 - Q1 (2020-03-31) | $1,406,000 | 1.32% | 569,405 | $4.50 |
| 17 | 2019 - Q4 (2019-12-31) | $3,308,000 | 2.44% | 569,405 | $5.78 |
| 18 | 2019 - Q3 (2019-09-30) | $2,801,000 | 2.56% | 531,568 | $5.38 |
| 19 | 2019 - Q2 (2019-06-30) | $3,176,000 | 2.6% | 529,390 | $7.53 |
| 20 | 2019 - Q1 (2019-03-31) | $4,371,000 | 3.32% | 484,096 | $8.50 |
| 21 | 2018 - Q4 (2018-12-31) | $4,018,000 | 4.57% | 484,096 | $10.25 |
| 22 | 2018 - Q3 (2018-09-30) | $6,317,000 | 5.33% | 484,096 | $8.11 |
| 23 | 2018 - Q2 (2018-06-30) | $987,000 | 0.83% | 124,096 | $7.98 |
| 24 | 2018 - Q1 (2018-03-31) | $931,000 | 0.95% | 124,096 | $7.59 |
| 25 | 2017 - Q4 (2017-12-31) | $844,000 | 0.74% | 124,096 | $6.59 |
| 26 | 2017 - Q3 (2017-09-30) | $893,000 | 0.76% | 124,096 | $5.22 |
| 27 | 2017 - Q2 (2017-06-30) | $583,000 | 0.77% | 124,096 | $4.60 |
| 28 | 2017 - Q1 (2017-03-31) | $620,000 | 0.93% | 124,096 | $5.15 |
| 29 | 2016 - Q4 (2016-12-31) | $727,000 | 1.27% | 135,800 | $5.87 |
| 30 | 2016 - Q3 (2016-09-30) | $1,038,000 | 1.82% | 135,800 | $6.11 |
| 31 | 2016 - Q2 (2016-06-30) | $773,000 | 0.25% | 135,800 | $5.59 |
| 32 | 2016 - Q1 (2016-03-31) | $569,000 | 0.23% | 135,800 | $4.81 |
| 33 | 2015 - Q4 (2015-12-31) | $921,000 | 0.34% | 135,800 | $6.72 |
| 34 | 2015 - Q3 (2015-09-30) | $792,000 | 0.33% | 135,800 | $7.81 |
| 35 | 2015 - Q2 (2015-06-30) | $1,054,000 | 0.33% | 135,800 | $8.62 |
| 36 | 2015 - Q1 (2015-03-31) | $1,382,000 | 0.4% | 135,800 | $10.20 |
The displayed share prices are average quarterly stock market prices.